Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bioshares Biotech Clinical Trial (BBC)

Bioshares Biotech Clinical Trial (BBC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BioShares
  • Assets Under Management 49,400,000
  • Shares Outstanding, K 950
  • 60-Month Beta 1.36
Trade BBC with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.30 (0.57%)
  • Most Recent Dividend 0.297 on 12/20/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.93 +9.88%
on 05/17/21
52.18 -3.28%
on 06/15/21
+4.37 (+9.49%)
since 05/14/21
3-Month
44.10 +14.44%
on 05/13/21
57.82 -12.71%
on 03/16/21
-6.92 (-12.05%)
since 03/15/21
52-Week
35.67 +41.49%
on 09/04/20
62.60 -19.38%
on 02/10/21
+9.01 (+21.75%)
since 06/15/20

Most Recent Stories

More News
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval

The approval for Biogen's Alzheimer's disease treatment has spread strong optimism, with many investors pulling in capital to this high growth and high beta sector.

BIIB : 401.12 (-1.24%)
LLY : 223.27 (-1.25%)
XBI : 133.52 (-2.31%)
BBC : 50.43 (-3.02%)
SBIO : 48.87 (-2.14%)
PBE : 76.11 (-1.23%)
GNOM : 22.86 (-2.10%)
Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

BMY : 67.42 (+0.19%)
XBI : 133.52 (-2.31%)
XPH : 52.35 (-1.07%)
BBC : 50.43 (-3.02%)
SBIO : 48.87 (-2.14%)
MYOK : 224.91 (+0.05%)
ARKG : 85.51 (-2.37%)
Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

AZN : 58.67 (-0.15%)
PFE : 39.58 (-0.13%)
GILD : 67.89 (-0.38%)
IMMU : 87.86 (+0.05%)
MRNS : 17.64 (-5.92%)
PTH : 163.61 (-1.65%)
WVE : 7.14 (-2.33%)
BBC : 50.43 (-3.02%)
BTEC : 58.64 (-2.22%)
NVUS : 14.60 (-5.19%)
SAVA : 73.00 (-3.68%)
IDNA : 48.50 (-2.18%)
IBBJ : 31.74 (-2.66%)
Biotech ETFs Soar on Gilead-Immunomedics Deal

The acquisition will expand Gilead's portfolio of treatments for various types of cancer.

GILD : 67.89 (-0.38%)
IMMU : 87.86 (+0.05%)
CNCR : 30.65 (-2.17%)
XBI : 133.52 (-2.31%)
PTH : 163.61 (-1.65%)
BBC : 50.43 (-3.02%)
Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

BBC : 50.43 (-3.02%)
BTEC : 58.64 (-2.22%)
IDNA : 48.50 (-2.18%)
IBBJ : 31.74 (-2.66%)
4 Best ETF Charts of Q1 Earnings

Below are four ETFs that buoyed up on strong earnings results.

MSFT : 258.23 (-0.64%)
IBM : 149.32 (-0.47%)
AMZN : 3,373.86 (-0.30%)
SPY : 424.13 (-0.27%)
GOOGL : 2,433.00 (-0.65%)
ITB : 67.59 (+0.46%)
IBUY : 123.20 (-2.14%)
BBC : 50.43 (-3.02%)
WCLD : 52.42 (-1.34%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 164.83 (-0.33%)
SNY : 53.94 (-0.57%)
PFE : 39.58 (-0.13%)
MRK : 75.51 (+0.08%)
MRNA : 201.46 (-2.87%)
GSK : 40.50 (+0.02%)
NVAX : 188.62 (-9.19%)
IBB : 159.40 (-1.51%)
XBI : 133.52 (-2.31%)
BBH : 194.51 (-1.71%)
BBC : 50.43 (-3.02%)
ARKG : 85.51 (-2.37%)
BNTX : 216.59 (-1.81%)
GNOM : 22.86 (-2.10%)
Biotech ETF (BBC) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

MRK : 75.51 (+0.08%)
NVAX : 188.62 (-9.19%)
BBC : 50.43 (-3.02%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 58.67 (-0.15%)
MRNA : 201.46 (-2.87%)
GSK : 40.50 (+0.02%)
NVAX : 188.62 (-9.19%)
CNCR : 30.65 (-2.17%)
INO : 8.66 (-2.81%)
PTH : 163.61 (-1.65%)
BBC : 50.43 (-3.02%)
BTEC : 58.64 (-2.22%)
ARKG : 85.51 (-2.37%)
IDN : 7.79 (+1.17%)
VXRT : 7.82 (-10.53%)
GNOM : 22.86 (-2.10%)
Top ETF Areas of Last Week

Wall Street was upbeat last week, mainly driven by these ETF areas.

USO : 48.88 (+1.16%)
BNO : 18.87 (+1.23%)
UGA : 34.75 (-0.54%)
IBUY : 123.20 (-2.14%)
BBC : 50.43 (-3.02%)
ARGT : 31.70 (-1.09%)
AGT : 27.14 (-1.01%)
BUYZ : 50.25 (-1.47%)
WCLD : 52.42 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The BioShares Biotechnology Clinical Trials Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their...

See More

Top 10 Holdings

Name % Holdings
Amyris Inc 3.08%
Prothena Corp PLC 2.24%
Rubius Therapeutics Inc 2.00%
BNY MELLON CASH RESERVE USD 1.26%
Verastem Inc 1.25%
BioCryst Pharmaceuticals Inc 1.24%
Protagonist Therapeutics Inc 1.20%
Morphic Holding Inc 1.19%
I-Mab 1.19%
DYNAVAX TECHNO 1.12%

See More

Key Turning Points

3rd Resistance Point 52.92
2nd Resistance Point 52.51
1st Resistance Point 52.26
Last Price 50.43
1st Support Level 51.59
2nd Support Level 51.17
3rd Support Level 50.92

See More

52-Week High 62.60
Fibonacci 61.8% 52.31
Last Price 50.43
Fibonacci 50% 49.13
Fibonacci 38.2% 45.96
52-Week Low 35.67

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar